Charles Schwab’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$362M Buy
749,607
+88,102
+13% +$23.4M 0.05% 306
2026
Q1
$72.5M Buy
661,505
+27,565
+4% +$3.93M 0.01% 914
2025
Q4
$105M Buy
633,940
+35,456
+6% +$5.93M 0.02% 707
2025
Q3
$117M Buy
598,484
+428,050
+251% +$70.4M 0.02% 627
2025
Q2
$15.4M Buy
170,434
+32,134
+23% +$2.54M ﹤0.01% 1802
2025
Q1
$8.25M Buy
138,300
+5,828
+4% +$539K ﹤0.01% 2043
2024
Q4
$17.5M Buy
132,472
+15,008
+13% +$1.41M ﹤0.01% 1769
2024
Q3
$6.15M Sell
117,464
-5,030
-4% -$236K ﹤0.01% 2268
2024
Q2
$7.41M Buy
+122,494
New +$8.5M ﹤0.01% 2181

Other funds holding ALAB

Charles Schwab's ALAB Position: Q2 2026 in Review

Charles Schwab increased its Astera Labs (ALAB) stake by 13% in Q2 2026, buying an estimated $23.4M and bringing the position to 749,607 shares worth $362M. The position accounts for 0.05% of the portfolio, ranked #306.

Charles Schwab first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Charles Schwab held 749,607 shares of Astera Labs worth $362M as of Q2 2026.
  • Charles Schwab bought 88,102 Astera Labs shares in Q2 2026, an estimated $23.4M.
  • Astera Labs made up 0.05% of Charles Schwab's portfolio in Q2 2026, its #306 holding.
  • Charles Schwab first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.